Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Paul Aliu"'
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Compassionate Use (CU)/Managed Access programs provide access to locally unapproved medicines. As these programs become more global and involve a broader range of products, determining whether patients derive benefit from treatment could provide insi
Externí odkaz:
https://doaj.org/article/94f719b17d4942d182470e8cec356a19
Autor:
Philip Heesen, Gabriela Studer, Beata Bode, Hubi Windegger, Benjamin Staeheli, Paul Aliu, Javier Martin-Broto, Alessandro Gronchi, Jean-Yves Blay, Axel Le Cesne, Bruno Fuchs
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 47
Sarcomas represent a large group of rare to very rare diseases, requiring complex management with a transdisciplinary approach. Overall progress has been hampered because of discipline, institution and network fragmentation, and there is no global da
Publikováno v:
JAMA health forum. 3(12)
This Viewpoint assesses patient access to compassionate use treatments for medical care and advocates a framework for helping to facilitate such access.
Autor:
Paul Aliu
Publikováno v:
Pharmaceutical Journal.
Autor:
Paul Aliu, Séverine Sarp, Ramona Reichenbach, Sigrid Behr, Paige Fitzsimmons, Mansurahmad Shamlajee, Surya Prakash Kola, Samantha Nunes Radimerski, Emil Scosyrev
Publikováno v:
JAMA health forum. 3(4)
Compassionate use (CU) is a treatment option for patients with serious or life-threatening medical conditions that provides access to locally unlicensed medications (generally free of charge) when all available treatment options have been exhausted a
Publikováno v:
Clinical Pharmacology and Therapeutics
Clinical Pharmacology & Therapeutics
Clinical Pharmacology & Therapeutics